Sapheon, Inc.

14 articles about Sapheon, Inc.

• How Sapheon, Inc. Went From An Idea On The Back Of A Napkin To A $240 Million Exit To Covidien

  4/15/2016

• Covidien's Buying Spree Continues, Picks Up Venous Disease Treatment Developer Sapheon, Inc. For Undisclosed Amount

  8/28/2014

• Sapheon, Inc. Venaseal® Receives Health Canada Approval; First Cases Performed In Vancouver And Toronto

  2/3/2014

• Sapheon, Inc. Submits Second Module Of PMA Application For Venaseal® Sapheon Closure System; Raises $10 Million In Bridge Note Financing

  1/7/2014

• Sapheon, Inc. Submits Second Module Of PMA Application For VenaSeal&0174 Sapheon Closure System; Raises $10M In Bridge Note Financing

  1/7/2014

• Sapheon, Inc. Submits First Module of PMA Application for VenaSeal® Sapheon Closure System

  9/20/2013

• Sapheon, Inc. Raises $19.8 Million in Series B Preferred Offering; U.S. Pivotal Study Completes Enrollment

  9/9/2013

• Sapheon, Inc. Announces Completed Enrollment in VenaSeal™ eSCOPE Study

  9/12/2012

• Sapheon, Inc. Holds First Close in $18.5 Million Series B

  8/24/2012

• Sapheon, Inc. Announces One Year Follow-up Data in 38-Patient Study of Varicose Vein Treatment

  8/10/2012

• Dieter Bielang Joins Sapheon, Inc. as International Sales Director, Europe

  4/4/2012

• Sapheon, Inc. Announces One Year First-In-Man Data; Enrollment Commences in European Post Market Study

  1/19/2012

• First German Patient Receives New Sapheon, Inc. Varicose Vein Treatment

  10/19/2011

• Sapheon, Inc. Receives CE Mark Approval for New Varicose Vein Treatment

  9/22/2011